Projects IrsiCaixa is involved in a hundred national and international research projects active each year, funded by both public and private entities. Breadcrumb Home Projects Keywords Research group - Any -Cell Virology and Immunology (VIC)HIV and HVC Genetic and Phenotypic VariabilityImmunology (IGG)Microbial Genomics (GEM)Neoantigens and Vaccines against Cancer (NeoVaCan)Pathogen Immunity, Signalling and Therapeutic Applications (PISTA)Retrovirology and Clinical Studies (GREC)T-cell Immunology and Vaccines (TIV)Tissue Virology (VITI)Translational Research in Immunology and Ageing (TRIA)Viral Immune Evasion and Vaccines (VIRIEVAC)Virus-Host Interactions (ViHIT) Researcher - Any -Aleix Elizalde TorrentAlejandro Riquelme GrauAlessandra BorgognoneAlex Olvera van der StoepAnaí Villanueva DelgadoAnna López PlanaAnna Pons GrifolsArnau Creus OrodeaBeatriz Mothe PujadasBenjamin TrinitéBonaventura Clotet SalaCarla Rovirosa MartíCarlos Ávila NietoCarmen Aguilar GurrieriCecilia Cabrera NavarroChristian BranderCristina GálvezCristina Mesa RealCristina Peligero CruzCristina Ramírez SotoDaniela Benítez CanoDaniel Pérez ZsoltDàlia Raïch ReguéEdurne García VidalEdwards Pradenas SaavedraElena Lapaz LorenzoElisabet Fernández RosasElisabet García RodríguezElisa Molina MolinaEloi Franco Trepat Erola Ainsua EnrichEster Ballana GuixEudald Felip FalgàsEudald Vehí PiquéEulalia Grau SegúEva Riveira MuñozFernando Laguía NuedaFerran Abancó i EspugaFrancesc Català MollFrancisco M. Muñoz LópezGabriel Felipe Rodríguez LozanoGerard Campos GonzalezGooya BanaeiGustavo Rodríguez EstebanIgnasi Calba IñiguezIgor Moraes CardosoIrene González NavarroItziar Erkizia JauregiJakub ChojnackiJavier Martínez-PicadoJoan Pagès OliverasJon Izquierdo PujolJordi Senserrich VelascoJorge Carrillo MolinaJosé Luis Pérez GuillamónJudith Dalmau MorenoJulia García PradoJulieta CarabelliJulià Blanco ArbuésJulián Eslava CampoJúlia Albó DelgadoLaia Bernad RosaLaia Vives AdriánLaura Planells FerrerLidia Garrido SanzLidia Ruiz TabuencaLluís Revilla SanchoLourdes Grau ParéLucía Gómez EspadaMacedonia Trigueros PeñaManel Garcia de la FuenteMarc Noguera i JulianMaria Casadellà FontdevilaMaria Nevot BanúsMaria Salgado BernalMarina Pino CebriánMariona Parera SallentMarissa Flores SantamaríaMarta Massanella LunaMarta Ruiz RiolMaría Lázaro DíezMiguel Marín LópezMiguel Ángel Martínez de la SierraMireia Martínez GameroMª Carmen García GuerreroMª Carmen Puertas CastroMª Luisa Rodríguez de la ConcepciónNatàlia Marrugat VilaNuria Izquierdo UserosNúria de la Iglesia ZaragozaNúria Pedreño LópezPatricia Piñol JuradoPatricia Resa InfantePenélope Riquelme NevadoRafaela Ayen AparicioRaúl Pérez CaballeroRita Casas CostaRoger Badia CórcolesRoger ParedesRosina Malagrida EscalasRuth Peña PoderósRytis BoreikaSamandhy Cedeño BriceñoSandra Franco CireraSandra Silva ArrietaSara Cabrero de las HerasSara Morón LópezSilvia Marfil VerchiliSonia Bange SinghSonia Villanueva HernándezSusana Esteban RayaSílvia Ribó GenéTeresa Puig OlivaTetyana PidkovaToni Navarro AlcarazTuixent Escribà BelValentina Triviño VenceVíctor Urrea GalesÁngel Bayón Gil From date To date Tumor-specific neoantigens as targets for personalized vaccines Project status Ongoing Start/End 2022 / 2024 Principal investigator Núria de la Iglesia Zaragoza Participating entities IrsiCaixa, ICO, Hospital Germans Trias i Pujol, CNAG-CRG Strategic lines Cancer Financing entity Instituto de Salud Carlos III IrsiCaixa collaborative researchers: Gustavo Rodríguez Esteban, Anna López Plana External collaborative researchers: Rafael Villanueva, Laura Layos, Holger Heyn Role of NK cells in post COVID-19 condition (LoNK-COVID) Project status Ongoing Start/End 2022 / 2025 Principal investigator Maria Nevot Banús Strategic lines Immunopathology Financing entity Ministerio de Ciencia e Innovación (PID2021-124226OB-I00) Genomic epidemiology of SARS-CoV-2 in Catalonia: virologic surveillance and outbreak control Project status Ongoing Start/End 2021 / 2023 Principal investigator Marc Noguera i Julian Participating entities IrsiCaixa, IGTP Strategic lines Cancer Emerging infectious diseases Financing entity Fundació "La Marató" de TV3 Eclipse Ts2R-FL Inverted Research Microscope Project status Ongoing Start/End 2021 / 2024 Principal investigator Christian Brander Participating entities IrsiCaixa Financing entity Dormeur Foundation, Vaduz In vitro antiviral screening of compounds provided by Pharma Mar on Ebola virus entry and on the replication of HIV-1, Zika and SARS-CoV-2 Project status Ongoing Start/End 2021 / 2022 Principal investigator Ester Ballana Guix Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Cancer Emerging infectious diseases Financing entity PharmaMar Impact of HIV envelope function and antigenicity on elite control of HIV replication Project status Ongoing Start/End 2021 / 2023 Principal investigator Julià Blanco Arbués Participating entities IrsiCaixa AIDS Research Institute, ISCII, Institut de Recerca Germans Trias i Pujol Strategic lines Immunopathology Financing entity ISCIII EU Research Scholars Program in HIV Project status Ongoing Start/End 2021 / 2023 Principal investigator Sara Morón López Participating entities IrsiCaixa Strategic lines Global infectious diseases Financing entity GILEAD Discovery of novel inhibitors of HIV-1 RNA biogenesis based on the inhibition of the ribonucleoprotein RRE-Rev Project status Ongoing Start/End 2021 / 2024 Principal investigator Javier Martínez-Picado Participating entities IrsiCaixa, ISCIII, University of Barcelona, Catholic University of Valencia Strategic lines Therapies and vaccines Reversing Immune Dysfunction for HIV-1 eradication Project status Ongoing Start/End 2021 / 2026 Principal investigator Javier Martínez-Picado Maria Salgado Bernal Participating entities IrsiCaixa, Emory University, University of Southern California, Scripps Research College Strategic lines Global infectious diseases Financing entity National Institutes of Health (NIH) Impact of synonymous HIV-1 genome recoding on virus immune response and latency Project status Ongoing Start/End 2020 / 2023 Principal investigator Miguel Ángel Martínez de la Sierra Participating entities IrsiCaixa AIDS Research Institute Strategic lines Immunopathology Financing entity Spanish Ministry of Science and Innovation (PID2019-103955RB-100) Pagination 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next Last
Tumor-specific neoantigens as targets for personalized vaccines Project status Ongoing Start/End 2022 / 2024 Principal investigator Núria de la Iglesia Zaragoza Participating entities IrsiCaixa, ICO, Hospital Germans Trias i Pujol, CNAG-CRG Strategic lines Cancer Financing entity Instituto de Salud Carlos III IrsiCaixa collaborative researchers: Gustavo Rodríguez Esteban, Anna López Plana External collaborative researchers: Rafael Villanueva, Laura Layos, Holger Heyn
Role of NK cells in post COVID-19 condition (LoNK-COVID) Project status Ongoing Start/End 2022 / 2025 Principal investigator Maria Nevot Banús Strategic lines Immunopathology Financing entity Ministerio de Ciencia e Innovación (PID2021-124226OB-I00)
Genomic epidemiology of SARS-CoV-2 in Catalonia: virologic surveillance and outbreak control Project status Ongoing Start/End 2021 / 2023 Principal investigator Marc Noguera i Julian Participating entities IrsiCaixa, IGTP Strategic lines Cancer Emerging infectious diseases Financing entity Fundació "La Marató" de TV3
Eclipse Ts2R-FL Inverted Research Microscope Project status Ongoing Start/End 2021 / 2024 Principal investigator Christian Brander Participating entities IrsiCaixa Financing entity Dormeur Foundation, Vaduz
In vitro antiviral screening of compounds provided by Pharma Mar on Ebola virus entry and on the replication of HIV-1, Zika and SARS-CoV-2 Project status Ongoing Start/End 2021 / 2022 Principal investigator Ester Ballana Guix Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Cancer Emerging infectious diseases Financing entity PharmaMar
Impact of HIV envelope function and antigenicity on elite control of HIV replication Project status Ongoing Start/End 2021 / 2023 Principal investigator Julià Blanco Arbués Participating entities IrsiCaixa AIDS Research Institute, ISCII, Institut de Recerca Germans Trias i Pujol Strategic lines Immunopathology Financing entity ISCIII
EU Research Scholars Program in HIV Project status Ongoing Start/End 2021 / 2023 Principal investigator Sara Morón López Participating entities IrsiCaixa Strategic lines Global infectious diseases Financing entity GILEAD
Discovery of novel inhibitors of HIV-1 RNA biogenesis based on the inhibition of the ribonucleoprotein RRE-Rev Project status Ongoing Start/End 2021 / 2024 Principal investigator Javier Martínez-Picado Participating entities IrsiCaixa, ISCIII, University of Barcelona, Catholic University of Valencia Strategic lines Therapies and vaccines
Reversing Immune Dysfunction for HIV-1 eradication Project status Ongoing Start/End 2021 / 2026 Principal investigator Javier Martínez-Picado Maria Salgado Bernal Participating entities IrsiCaixa, Emory University, University of Southern California, Scripps Research College Strategic lines Global infectious diseases Financing entity National Institutes of Health (NIH)
Impact of synonymous HIV-1 genome recoding on virus immune response and latency Project status Ongoing Start/End 2020 / 2023 Principal investigator Miguel Ángel Martínez de la Sierra Participating entities IrsiCaixa AIDS Research Institute Strategic lines Immunopathology Financing entity Spanish Ministry of Science and Innovation (PID2019-103955RB-100)